- CA$653.37m
- CA$579.00m
- $17.68m
- 30
- 10
- 77
- 33
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 32.3 | 8.32 | 0.016 | 0.019 | 17.7 |
Cost of Revenue | |||||
Gross Profit | 1.98 | -4.65 | -6.98 | -6.84 | -1.69 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 40.5 | 21.7 | 15.9 | 19.8 | 48.5 |
Operating Profit | -8.29 | -13.3 | -15.9 | -19.8 | -30.8 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -8.42 | -14.8 | -22.9 | -17.1 | -30.7 |
Net Income After Taxes | -8.42 | -14.8 | -22.9 | -17.1 | -30.7 |
Net Income Before Extraordinary Items | |||||
Net Income | -8.42 | -14.8 | -22.9 | -17.1 | -30.7 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -8.42 | -14.8 | -22.9 | -17.1 | -30.7 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.053 | -0.09 | -0.122 | -0.078 | -0.118 |